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A variety of murine transplantable tumors have been found to be immunosup- 
pressive. In the case of viral-induced neoplasms, immunosuppression could often 
be related to the effects of the corresponding oncogeneic type C virus (1-3).  In 
the case of chemically induced or spontaneous neoplasms, the concept has been 
raised that tumor cells,  or their metabolic soluble products, were immunosup- 
pressive (4-6). In a previous study, 1 a subline of EL-4 lymphoma, EL-4(G-), was 
shown to have strong inhibitory effects on allogeneic mixed lymphocyte cultures 
(MLC) 2 in vitro.  EL-4 is a  chemically induced,  thymus-derived transplantable 
tumor of C57BL mice (7, 8), which contains endogenous type C viruses (reference 
9 and footnote 3), and is also contaminated by common murine viruses. 
In the present study, we report on our findings of common virus contamina- 
tion of the EL-4(G-)  subline maintained in our laboratory.  We have accumu- 
lated evidence consistent with the hypothesis that the inhibitory activity of EL- 
4(G-) ascites cells and the culture fluid was mediated by an infectious virus. At 
the present time, the best candidate for this activity is a variant of minute virus 
of mice (MVM). 
Materials and Methods 
Mice.  Male BALB/c and C57BL/6 mice,  5- to 7-wk old, and pregnant NIH Swiss  mice were 
obtained from the Animal Production Unit, National Institutes of Health (NIH),  Bethesda, Md. 
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Male NIH Swiss mice, 3-wk old, for the mouse antibody production tests, were from the colony 
raised at Microbiological Associates, Bethesda, Md. 
Tumor System.  EL-4 is a  thymus-derived, benzopyrene-induced lymphoma of C57BL mice, 
which has been carried as a transplantable ascitic tumor for many years (7, 8).  According to the 
presence or absence of serologically detectable Gross cell surface antigen, we distinguish in this 
laboratory an EL-4(G+) and an EL-4(G-) subline (9). Two tissue culture lines of EL-4(G-), A and 
B,  and one  EL-4(G+)  tissue culture  line,  were  initiated at the  onset of this study,  and then 
maintained as described elsewhere.1 Each of the EL-4 ascites tumor sublines and tissue culture 
lines was repeatedly tested and found free of contamination by mycoplasma.' 
Ascitic Fluid.  Ascitic fluids were harvested, 5-7 days after tumor inoculation, in 10 ml Hanks' 
balanced salt solution. This, depending on the volume of the ascites, resulted in an approximate 
1:5 dilution. Tumor cells were removed by centrifugation at 150 g  for 10 min, and the cell-free 
fluids were filtered through a 0.22 ~m membrane (Nalge Co., Nalgene Labware Div., Rochester, 
N.  Y.) and kept at 4°C for up to 8 wk. 
Harvest and Treatments of the Tissue Culture Fluids.  Early in vitro passages of both EL-4(G-) 
tissue culture lines A and B were fed daily. Culture fluids were harvested from many flasks and 
pooled in 500-ml atiquots, between the 13th day and the 25th day in vitro. Later passages of the 
EL-4(G-) tissue culture lines A  and B  were fed every 3 days,  thus resulting in a  considerably 
lower rate of growth. After centrifugation to remove tissue culture cells,  all culture fluids were 
further filtered through 0.22 ~m membranes. The culture fluids were numbered chronologically at 
the time of harvest. After the initial screening of the effects of these culture fluids, only the culture 
fluid no. 4 was studied in depth.  10-ml samples of culture fluid no. 4 were dialyzed three times 
against 500 ml of phosphate-buffered saline, pH 7.4, at 4°C. The material within the dialysis bag 
was used at the same dilutions and in parallel with the nondialyzed culture fluid. 10-ml samples of 
culture fluid were ultracentrifuged at 100,000g for 1 h at 4°C (Type 50 rotor, Model L ultracentri- 
fuge,  Beckman Instruments, Inc., Fullerton, Calif.).  Pellets were resuspended in 3 ml of Hanks' 
balanced salt solution and they and the supernate were stored at 4°C until use.  2-ml samples of 
culture fluid were treated with UV irradiation. This was performed by rocking the samples in a 
watchglass at a distance of 27.6 cm from two 15 W germicidal tubes, thus providing 67 electroreti- 
nograms/mm2/s.  1.8  ml  culture  fluid,  or  culture  medium  as  control,  were  mixed  with  0.2  ml 
chloroform (Mallinckrodt Chemical Works, St. Louis, Mo.) for 10 min at 22°C,  then centrifuged 10 
min at 150 g, at 4°C,  and the aqueous phase overlying the chloroform was harvested. 
Inhibition of MLC with Culture Fluid.  For demonstrating inhibition, 1 ml of culture fluid or 
treated culture fluid was added to MLC  (see below) at their onset; this resulted in a  1:5 final 
dilution. Higher final dilutions were also used,  as indicated. 
Detection of Lactic Dehydrogenase  Virus (LDV Test).  For detection of LDV (10,  11) in various 
materials from EL-4(G-) origin, three weanling male NIH Swiss mice were inoculated, 0.05 ml 
intraperitoneally and 0.03 ml intracranially, with a  1:10 dilution of the test specimen. Controls 
included three mice inoculated with LDV and three mice injected with diluent only.  Mice were 
bled from the retroorbital sinus after 3 days and the plasma was tested for an increase in the lactic 
dehydrogenase enzyme level, as compared to the negative controls. 
Mouse Antibody Production Tests (MAP Test).  The testing of various materials for contamina- 
tion with 11 further common murine viruses, indicated in the legend of Table III, was performed 
by the MAP test (12), as described in detail elsewhere (10). The EL-4(G-) ascites tumor cells were 
washed twice in Hanks' balanced salt solution and resuspended at 2 ×  108 cells/ml. The EL-4(G-) 
tissue culture cells were from the line A after 246 days in culture. The cells were washed twice and 
resuspended in Hanks' balanced salt solution at a  concentration of 2  ×  107 cells/ml. They were 
representative of the later passages of EL-4(G-) tissue culture cells, which had lost the inhibitory 
capacity on MLC 1 (Table I). Each material to be tested was inoculated to four weanling male NIH 
Swiss  mice  both  intranasally  and  intraperitoneally.  As  a  control  for  inoculation  with  each 
material, four littermates were injected with sterile, fresh tissue culture medium. 4 wk later, mice 
were bled under sterile conditions, from the retroorbital sinus. The sera were collected individ- 
ually, diluted 1:5 in phosphate-buffered saline, heated at 56°C for 30 min, and tested, as reported 
earlier (13).  Either the hemagglutination inhibition (HI) or complement fixation (CF) techniques 
were used for detection of antibodies against the panel of 11 common murine viruses as explained 
in the legend of Table III. Then the sera were pooled for each group of four mice and stored at 
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Kilham Rat Virus.  A  cesium chloride density gradient purified preparation  of Kilham rat 
virus (14),  which has been shown in our laboratory to have profound inhibitory effects on the 
proliferative responses of rat lymphocytes in vitro, was used at similar concentrations and tested 
for its ability to inhibit the cytotoxic response in mouse MLC. 
Prototype MVM and Polyoma Virus.  The original strain of MVM was a  gift from Dr.  L.  V. 
Crawford,  Institute  of Virology,  Glasgow,  Scotland  (15).  The  production  of  MVM  pools  was 
performed as described earlier on either mouse or rat embryo tissue culture cells (16, 17). These 
MVM pools have been used extensively as prototype MVM; so far, contamination by other viruses 
has not been detected. In the present study, five different pools of MVM were used, two as virus 
pools (no.  1 and no.  2),  and three to raise the reference anti-MVM immune sera.  The original 
strain of polyoma virus was a  gift from Dr. W. L. Rowe,  Laboratory of Viral Diseases,  National 
Institute  of Allergy  and  Infectious  Diseases,  Bethesda,  Md.  (12).  The  production  of pools  of 
polyoma virus was achieved as described earlier (13). In this study, three different pools were used 
to raise the reference antipolyoma virus immune sera.  Each fresh pool of virus was tested at 
Microbiological  Associates,  Bethesda,  Md.,  for  purity  by  the  LDV  and  MAP  tests.  Further, 
hemagglutination titers were measured and infectivity, both in vivo and in vitro, was established 
for each pool. The pools were cryopreserved at -75°C until use. 
Mouse Reference Anti-MVM or Antipolyoma Virus Immune Sera.  The reference immune sera 
were raised with the viruses described above. These immune sera were tested serologically (10, 13) 
against the panel of viruses given in the legend of Table III. All reference immune sera have been 
extensively used as diagnostic reagents for MVM and polyoma virus, respectively, at Microbiologi- 
cal  Associates,  for screening biological materials for  many investigators in the  Virus Cancer 
Program.  They  did  not  appear  to  have any  detectable  activity  against  other  viruses  in  the 
diagnostic panel.  The HI titers of these sera were as follows: anti-MVM immune serum no.  7, 
1:640; no. 8, 1:80; and no. 9, 1:2,560; antipolyoma virus immune serum no. 10, 1:1,280; no. 11, 1:512; 
and no.  12,  1:320. 
Neutralization Assays.  Ascitic  fluids,  immune  sera,  or  control  sera  were  tested  for  their 
ability to neutralize various inhibitory materials, usually culture fluid or EL-4(G-) ascites cells. 
Typically,  0.1 ml of inhibitory material was incubated for 1 h  at 22°C with various volumes of 
ascitic fluid preparations or with 0.1 ml of various dilutions (1:10-1:1,000) of immune or control 
sera.  The stimulating cells were  then added and the mixtures immediately transferred to the 
responding cells in the culture flasks (see below). Final dilutions of ascitic fluid in the MLC have 
been calculated,  whereas dilutions of antisera used in the neutralization assay are given, and 
should be divided by a factor of 50 to obtain the final dilutions in MLC. 
In  Vitro  MLC  Technique.  The  technique  of MLC  was  as  described  elsewhere. 1 For  each 
experiment, triplicate MLC with 5  ×  106 BALB/c responding spleen cells and 2  ×  108 C57BL/6 X- 
irradiated stimulating spleen cells in 4.5 ml medium served as positive control. One culture with 5 
×  10  e BALB/c spleen cells alone in 4.5 ml medium served as negative control. The experimental 
cultures were performed by adding various materials, usually culture fluid and/or sera, in various 
final dilutions to MLC. The cultures were incubated in standing 30 ml flasks and then harvested 
for the assessment of the generation of cytotoxic lymphocytes. 
Lymphocyte-Mediated  Cytotoxicity  (LMC).  Cytotoxicity was measured in 4-h 15Cr-release as- 
says as described elsewhere. ~ 1, 0.3, or 0.1 ml of effector cell suspension from the MLC were tested 
in duplicate against 2  ×  104 5~Cr-labeled RBL-5 ascites target cells,  a  C57BL/6 Rauscher virus- 
induced  leukemia.  Thus,  the  ratios  of effector  cells  to  target  cells,  based  on  the  number of 
responding lymphocytes initially present in the MLC, (lymphocyte to target cell ratios) were 60:1, 
20:1,  and 6:1, respectively.  The reaction mixtures were all made up to 2 ml with medium. The 
values of LMC are expressed as percentages of 5~Cr release compared to the total 5aCr label of the 
target cells. The spontaneous release occurring in medium alone was always less than 10%,  and 
this was  subtracted from the  experimental percent release.  The standard errors of the means 
between duplicates rarely exceeded 3% and are not given in the results. 
Results 
Inhibitory Activity in Tissue Culture Fluids from EL-4(G ~ ) Cells, Stored at 
4°C or  -75°C.  In the previous  study, 1 we reported  on the  strong inhibitory 
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passages of the EL-4(G-) tissue culture cells, on the proliferative and cytotoxic 
responses  in  MLC.  It  was  important  to  study the  stability of the  inhibitory 
activity of the culture fluids,  since consistently strong effects were needed for 
detailed biophysical and/or virological characterization.  The culture fluids were 
stored in aliquots  at 4°C  and  -75°C,  and tested several times.  In the typical 
experiment shown in Fig. 1 A, 1 ml of culture fluids stored for 11 mo at 4°C were 
added  to  BALB/c vs.  C57BL/6 MLC  at  the  onset of culture.  As  initially  ob- 
served,1 strong inhibitory activity was present in early culture fluids. Culture 
fluid  no.  3,  from a  later passage  of the  EL-4(G-)  tissue culture  line  A,  was 
virtually  noninhibitory.  Similar  results  were  repeatedly  obtained  with  the 
culture fluids stored at either 4°C or -75°C. In subsequent experiments, we used 
culture fluid no. 4, which had been harvested from EL-4(G-) tissue culture line 
B after 13 days in culture and was stored at  -75°C. This will be subsequently 
referred to as "the culture fluid." The effects of the culture fluid on the cytotoxic 
response  in  MLC were strictly dose dependent,  with  increasing  inhibition  of 
cytotoxicity by increasing concentrations of added culture fluid (Fig. 1B). Accord- 
ing to a simple calculation, these data revealed further that, within the range of 
doses tested (1:5-1:500 final dilution of culture fluid), a  10-fold increase in the 
concentration of the culture fluid resulted in approximately a  10-fold reduction 
in the number of effector cells. 
Inhibitory activity could no longer be found in culture fluids of later passages 
of the EL-4(G-) tissue culture lines A and B (Table I). Further investigations 
were then performed with the culture fluid no. 4 to determine the nature of the 
inhibitory  activity  and  its  relationship  to  the  inhibition  by the  tumor  cells 
themselves. 1 
Biophysical Properties  of the Inhibitory Factor in the Culture Fluid.  The 
inhibitory  activity of the culture fluid was resistant  to at least four cycles of 
freezing and thawing in alternate alcohol-Dry Ice and 37°C water baths. It was 
resistant to 56°C for 1 h  at least, but its activity was lost after 20 min at 100°C. 
All of the culture fluids tested had been passed through a  0.22/~m filter before 
use. Further filtration through  a  0.10/~rn filter had only a  slight effect on the 
activity. When the culture fluid was dialyzed against phosphate-buffered saline, 
the material retained in the dialysis bag was practically as active as the original 
material  at inhibiting a  BALB/c vs. C57BL/6 MLC. 
The culture fluid was then ultracentrifuged at 100,000g for 1 h. The supernate 
was harvested and filtered through a 0.22 ~m filter. The pellet was resuspended 
in  one-third  of the  original  volume  in  Hanks'  balanced  salt  solution,  and 
filtered.  The effects of these materials  on the  MLC are shown in Fig.  2.  The 
100,000 g  supernate had lost most of the inhibitory activity, whereas the pellet 
had strong activity. 
The culture fluid was also exposed to UV irradiation and tested for residual 
inhibitory activity (Fig.  3). The UV-irradiated material had lost the inhibitory 
activity. Taken together, the biophysical characteristics above were compatible 
with the inhibitory factor being a virus. 
The resistance of the inhibitory factor to chloroform was tested to determine 
whether  the  agent  had  a  lipid  envelope  as  in  the  case  of mycoplasma  or BONNARD,  MANDERS~  CAMPBELL,  HERBERMAN,  AND  COLLINS  191 
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FIG.  1.  Inhibitory activity of culture fluids of EL-4(G-) tissue culture cells, after storage 
for 11 mo at 4°C. Percent LMC at three different lymphocyte  to target cell ratios were 
determined for the BALB/c vs. C57BL/6 MLC (J--I) and for the MLC with added culture 
fluid (C)---C)). (A) Each of 5 culture fluids were added at a 1:5 final dilution.  (B) Culture fluid 
no. 4 was added to the MLC at various concentrations  (numbers indicate the reciprocal of 
the final dilution). 
enveloped viruses (18). The results of these experiments are shown in Table II. 
The inhibitory factor was clearly resistant to chloroform treatment. 
Evidence for Infectivity of the Inhibitory Factor.  Since culture fluids of later 
passages of EL-4(G-) tissue culture cells had been consistently noninhibitory in 
MLC, we performed experiments to determine whether these cells were suscepti- 
ble to infection with the inhibitory factor. In a  typical experiment,  2 ml of the 
culture fluid no. 4 (or 2 ml of medium as control) were added to 8 ml of medium 
containing 4  x  l0  s cells of a  late passage of EL-4(G-) tissue culture line A. The 
addition of the culture  fluid had no effect on the rate of growth of the cells, as 
assessed by regular cell counts and [3H]thymidine pulses.  The cells were spun 
down and resuspended at 5  x  105/ml in fresh medium on days 3, 8, and 12, and 
these  secondary culture fluids were tested in MLC (Fig.  4).  Secondary culture 
fluids harvested at 8 and 12 days were more strongly inhibitory than the culture 
fluid no.  4.  A  1:500  dilution  of each  secondary fluid produced  almost as much 
inhibition as 10-fold more of the original culture fluid. It clearly appeared that 
the EL-4(G-) cells, upon inoculation with the inhibitory culture fluid,  started 
anew  to  produce  an  inhibitory  factor,  presumably  the  same  as  that  in  the 
original culture fluid. This was consistent with the possibility of a reinfection of 
the later passages of EL-4(G-) cells by an immunosuppressive virus. In further 
experiments,  we  found  that  these  infected  EL-4(G-)  cells  themselves  were 
strongly inhibitory, whereas the uninfected culture cells tested in parallel were 
not. 
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TABLE I 
Absence of  Inhibitory Activity in Culture Fluids of  Later Passages of the EL-4 (G -) 
Tissue Culture Lines A  and B 
Culture fluid 
EL-4(G-) line  Time in culture  number 
LMC at the lymphocyte/target cell 
ratios 
20/,~  60/1 
days  ~ 
None  --  --  33.7  53.6 
1  A  15  2.1  7.4 
9  A  41  40.4  64.2 
12  A  69  30.6  53.8 
4  B  13  1.1  4.5 
6  B  19  22.4  46.8 
7  B  19  40.3  64.2 
8  B  28  34.7  56.8 
10  B  56  41.1  59.4 
11  B  57  40.2  59.9 
13  B  145  31.3  50.7 
The  following cultures  were  set  up  and  harvested  on  day  6 for LMC  at  two different 
lymphocyte to target cell ratios: (a) BALB/c vs. C57BL/6 MLC (triplicate cultures). (b) MLC 
with addition of various culture fluids at the 1:5 final dilution. 
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Fro.  2.  Inhibitory activities of 100,000g supernate and pellet of culture fluid no. 4. Percent 
LMC were determined at the 60/1 lymphocyte to target cell ratio for BALB/c cells cultured 
alone (D), the MLC (I), the MLC in presence of various dilutions of culture fluid (O--C), 
100,000g supernate (e---e), or 100,000g pellet (@--e). The pellet had been resuspended in 
a third of the original volume before testing. 
another  approach  to detect viral contamination,  various materials  used in the 
present or earlier experiments  were tested for LDV,  and screened in the MAP 
test for the presence of 11 common murine viruses (Table III). Polyoma virus and 
MVM  were found in the  culture fluid when  tested  7  mo after harvesting.  The 
EL-4(G-)  ascites tumor  was also contaminated  with polyoma virus and MVM; BONNARD,  MANDERS,  CAMPBELL,  HERBERMAN,  AND  COLLINS  193 
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FIG.  3.  Effect of UV irradiation on inhibitory activity of the culture fluid. Percent LMC 
were determined at the 60/1 lymphocyte to target cell ratio, for BALB/c cells cultured alone 
([:2), the BALB/c vs.  C57BL/6 MLC  (B), and MLC  in presence of various dilutions of the 
culture fluid (©--O) or UV-irradiated culture fluid (0--0). 
in addition, LDV was also detected. In contrast, later passages of the EL-4(G-) 
tissue  culture  line  A  did not appear to have  any of these  viruses.  Since the 
culture fluid and the EL-4(G-) ascites cells were consistently inhibitory,  con- 
tamination  with  MVM  and  polyoma  virus  correlated  with  their  inhibitory 
activity. However, the role of other viruses could not be excluded on this basis. 
Neutralization  of the Inhibitory  Factor  by Ascitic Fluid from  Some  Mice 
Bearing EL-4(G-)  Ascites  Tumors.  In  preliminary  experiments,  we  found 
that cell-free ascitic fluids from EL-4(G-) tumor-bearing mice, as opposed to the 
culture fluid, had no inhibitory activity on MLC. It was conceivable then that 
ascitic fluids,  which  were harvested  5-8 days after tumor inoculation,  might 
already contain detectable levels of antibodies to the inhibitory factor from EL- 
4(G-) cells. If so, serological analysis of ascitic fluids might provide information 
on the inhibitory factor. We therefore performed HI or CF serological tests on 20 
consecutive ascitic fluids from EL-4(G-) or EL-4(G+) ascites,  from which the 
tumor  cells  were used  in  experiments  reported  earlier. 1 These  ascites fluids 
contained no detectable HI antibodies against polyoma virus or MVM; antibod- 
ies against mouse hepatitis virus and/or Sendai virus were present in only a few 
ascitic fluids, but this did not correlate at all with prior injection of the inhibi- 
tory EL-4(G-) ascites cells. Experiments were then performed in which various 
amounts of ascitic fluid were mixed with 0.1 ml of the culture fluid, incubated 
for 1 h  at 22°C,  and then added to the BALB/c vs. C57BL/6 MLC (Fig.  5). The 
results indicated that many ascitic fluids of EL-4(G-) mice could counteract the 
inhibitory factor found in the culture fluid. These data were consistent with, but 
did  not  prove,  the  hypothesis  that  the  ascites  fluid  contained  neutralizing 
antibodies against the inhibitory factor. 
Neutralization of the Inhibitory Factor by the Immune Sera from the MAP 
Test.  We performed further  neutralization  tests with the pooled sera of the 
three groups of mice which had been immunized for the MAP test (see Table III). 
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TABLE  II 
Effect of Chloroform on the Inhibitory  Activity of the Culture Fluid 
Addition to MLC  Final dilution 
LMC in MLC with culture fluid or 
control medium 
Treated with chlo- 
Untreated  roform 
None 
Culture fluid 
Medium 
% 
81.9 
1:5  ND*  0.1 
1:15  3.2  0.4 
1:50  7.3  7.8 
1:150  70.1  46.8 
1:500  81.4  70.9 
1:5  82.0  0.0 
1:15  81,7  79.1 
1:50  ND  81.7 
1:150  ND  80.1 
1:500  ND  78.8 
The following cultures were set up and harvested on day 6 for LMC at the 60/1  lympho- 
cyte/target cell ratio. (a) BALB/c vs. C57BL/6 MLC (triplicate cultures). (b) MLC with the 
addition of culture fluid or control medium, untreated or previously treated with chloro- 
form. 
* ND,  not done. 
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FIG.  4.  Inhibitory activities of the culture fluid  (O--O),  and of two  secondary culture 
fluids harvested 8 days (O---O),  and 12 days (O.-.O) after inoculation of EL-4(G-) tissue 
culture cells with the culture fluid no. 4. Percent LMC at the 60/1 lymphocyte to target cell 
ratio for the BALB/c cells cultured alone ([~), the BALB/c vs. C57BL/6 MLC (I), and MLC in 
presence of the indicated dilutions of the three culture fluids. 
in the MAP test and had no activity against any virus in the panel,  were also 
tested.  None of the sera, when added alone at dilutions of 1:500 or more, were 
found to have any effects on the BALB/c vs. C57BL/6 MLC. The sera were then BONNARD~  MANDERS~ CAMPBELL~  HERBERMANp AND  COLLINS  195 
TABLE III 
Viral Contamination of the Culture Fluid, EL-4(G-) Ascites and Tissue Culture Cells, 
as Assessed in the LDV and MAP Tests 
MAP  test§ 
Date of  Sera 
EL-4(G-)-derived  Inhibition  LDV 
sam-  material tested  of MLC  tests  Serum titer In against:  pool 
pling*  Polyoma vi-  MVM  no.¶ 
rus 
07/09/74  Culture fluid  +  -  160  160  1 
02/15/75  Ascites cells  +  +  160  320  2 
02/15/75  Tissue  culture  cells,  -  -  <10  <10  3 
Line A 
* All materials were tested, by inoculation of mice, on 02/15/75. 
Tests for LDV were carried out as described and the plasma tested for a 5- to 10-fold increase in 
the enzyme lactic dehydrogenase (+) or normal level of this enzyme (-). 
§ MAP tests were performed as described, and the sera tested against the following antigens. By 
HI:  pneumonia virus  of mice,  K  virus,  reovirus  type  3,  Theiler's encephalomyelitis virus, 
polyoma virus, MVM, and ectromelia virus.  By CF: Sendai virus, mouse adenovirus, mouse 
hepatitis virus, and lymphocytic choriomeningitis virus. All tests were negative, except those 
with polyoma virus and MVM, which are shown. All tests with control sera were negative. 
II From the four individual mouse sera tested, the reciprocal of the second highest HI titer is 
reported. Titers in the three other mice were the same, or did not differ by more than one 
dilution. The individual sera were subsequently pooled. 
¶ Once pooled, sera were given an arbitrary number, in the chronological order of their use. 
tested for their ability to neutralize the inhibitory effects of the culture fluid 
(Table IV). The results indicated that the two immune sera with both antipoly- 
oma virus and anti-MVM activities were able to neutralize the inhibitory effects 
of the culture fluid, at very high dilutions. The serum no. 2 was raised in mice 
which presumably underwent an LDV infection also, as indicated by the results 
of the LDV test. However, LDV-infected mice do not form detectable neutraliz- 
ing anti-LDV antibodies (19, 20), and it was not probable that such antibodies 
played a role here. The immune serum no. 3 with no activity against any virus 
in the panel had no neutralizing activity. Likewise, the three normal sera used 
as  controls  did  not  neutralize.  These  experiments  suggested  that  reference 
immune sera could be used for the identification of the inhibitory agent. The 
data further suggested that the inhibitory factor on the culture fluid might be 
either polyoma virus or MVM. 
Neutralization of the Inhibitory Factor by Anti-MVM Immune Sera. Experi- 
ments  were  performed  in  order  to  assess  the  neutralizing effects of mouse 
reference antipolyoma virus or anti-MVM immune sera (Table V). Each of the 
three different reference anti-MVM sera, but none of the reference antipolyoma 
virus sera, was able to neutralize the inhibitory effects of the culture fluid. The 
results indicated that inhibitory culture fluid could be neutralized by specific 
antibodies.  This neutralizing activity was found in reference  anti-MVM im- 
mune sera and could be directed against either MVM, or against an unidentified 
contaminant of the prototype MVM pools used to raise the reference sera. 
Identity between the Inhibitory Factors in EL-4(G-) Cells and in the Culture 
Fluid.  The above data indicated that a  virus, neutralized by reference anti- 196  IMMUNOSUPPRESSIVE  VIRUS  IN  A  MURINE  TUMOR 
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Fro.  5.  Neutralization of the inhibitory activity of the culture fluid by ascitic fluid from 
mice bearing EL-4(G-) tumor. Percent LMC at the 60/1 lymphocyte to target cell ratio, for 
the BALB/c vs. C57BL/6  MLC (m), the MLC with a  1:50 dilution of the culture fluid (©), 
MLC with culture fluid preincubated with various doses of ascitic fluid (A--A), and MLC 
with various doses of ascitic fluid (A--A). 
TABLE  IV 
Effect on the Inhibitory Activity of Culture Fluid by Sera from Mice used in MAP Tests 
EL-4(G-)-derived 
Serum  Known antiviral activ- 
material used to inoc- 
no.  ulate mice  ity 
Dilutions of the sera used in the 
neutralization phase 
1:10  1:100  1:1,000 
1  Culture fluid 
2  Ascites cells 
3  Tissue  culture  cells, 
line A 
4  Control medium 
5  Control medium 
6  Control medium 
Polyoma, MVM  77.8*  71.7  42.3 
Polyoma, MVM  75.3  78.2  77.0 
None  7.7  0.7  6.3 
None  5.6  3.5  ND$ 
None  9.5  11.2  ND 
None  12.6  17.1  ND 
The following cultures were set up and harvested on day 6 for LMC at the 60/1 lymphocyte to 
target cell ratio:  (a)  BALB/c vs. C57BL/6  MLC (triplicate cultures).  Median LMC, 77.3%.  (b) 
MLC inhibited with 0.1 ml of the culture fluid (five cultures). Median LMC, 6.0%.; range, 3.8- 
9.6%.  (c) MLC with the addition of 0.1 ml of various dilutions of normal or immune sera. The 
range of LMC in those cultures was 65.6-83.0%.  (d) MLC with the addition of 0.1  ml of the 
culture fluid and 0.1 ml of the indicated dilutions of the immune or control sera. Culture fluid 
and dilutions ofsera were preincubated 1 h at 22°C with occasional shaking, before their addition 
to the MLC. Mixing with the MLC resulted in a further 50-fold dilution of the immune sera. 
* % LMC. 
$ ND, not done. 
MVM immune sera, was the inhibitory factor in the culture fluid from the early 
passage of EL-4(G-) cells in culture. It was important to demonstrate that the 
inhibitory activity of the fresh ascites cells and of the sonicate of these cells' was 
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TABLE V 
Effects of  Reference Anti-MVM and Antipolyoma Immune Sera on Inhibitory 
Activity of Culture Fluid on MLC 
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,qno ifi  itv of im-  Serum no.  _~vc-_c._, 
mune serum 
Dilutions of the sera used in the neutralization 
phase 
1:10  1:100  1:1,000 
7  MVM  57.2*  12.4  5.4 
8  MVM  46.6  44.4  14.5 
9  MVM  42.9  48.7  40.8 
10  Polyoma  5.4  2.6  1.0 
11  Polyoma  3.3  7.4  4.0 
12  Polyoma  9.3  3.1  3.2 
The following cultures  were set up and harvested  on day 6 for LMC at the 20/1 
lymphocyte to target cell ratio: (a) BALB/c  vs. C57BL/6 MLC (triplicate cultures). 
Median LMC, 41.8%. (b)  MLC  inhibited  with  0.1  ml  of the culture  fluid  (five 
cultures). Median LMC, 3.5%; range: 2.1-4.9%. (c) MLC with the addition of 0.1 ml 
of the culture fluid and 0.1 ml of the indicated dilutions of the mouse antipolyoma 
virus or anti-MVM immune sera. Culture fluid and dilutions of sera were preincu- 
bated 1 h at 22°C with occasional shaking,  before their addition to MLC. Mixing 
with MLC resulted in a further 50-fold dilution of the immune sera. The effects of 
0.1 ml of  various dilutions of  all the sera themselves on the MLC were negligible. 
* % LMC. 
the effects of the reference anti-MVM immune sera on the inhibition produced 
by the EL-4(G-) ascites cells or senicates of the ascites cells. As with the culture 
fluid,  the  inhibitory  activity of the  whole  cells  and of the  sonicate  was com- 
pletely neutralized by anti-MVM serum and not by antipolyoma serum (Table 
VI).  Further,  anti-MVM sera also neutralized  the  inhibition mediated by the 
secondary culture fluids, obtained after infection of the later passages of the EL- 
4(G-) tissue culture cells. 
Effects  of Prototype MVM and  of an Isolate  of Kilham  Rat  Virus  on  the 
MLC.  In order to find out whether MVM was immunosuppressive in alloge- 
neic MLC,  two pools of prototype MVM were repeatedly used at various dilu- 
tions in BALB/c vs. C57BL/6 MLC. Typical results are shown in Table VII. The 
prototype MVM had a  slight enhancing effect on the cytotoxic response in MLC. 
In the same experiments, doses of Kilham rat virus, which have been reported to 
strongly inhibit rat proliferative responses in vitro (D. A. Campbell, Jr. and E. 
K.  Manders,  unpublished  results),  were  tested  for inhibition  of cytotoxic re- 
sponse in mouse MLC, and they were found to have no detectable effect. 
Discussion 
There have been a  considerable number of reports on the immunosuppressive 
properties of chemically induced or spontaneous murine tumors in vivo (4, 5, 21, 
22).  Very rarely did  these  reports  elucidate  the  cause  of such  inhibition.  Re- 
cently, a  few investigators have studied the immunosuppressive effects of the 
tumor cells or their products in in vitro asays of lymphocyte responsiveness (6, 
23,  24).  Although potentially very useful, these studies have not yet identified 
the causes for inhibition in these systems. The available evidence would suggest 198  IMMUNOSUPPRESSIVE  VIRUS  IN  A  MURINE  TUMOR 
TABLE  VI 
Effects of Reference Anti-MVM and Antipolyoma Virus Sera on Inhibitory Activity of 
EL-4(G-) Ascites Cells, Sonicate, and Culture Fluid No. 4 
EL-4(G-)-derived 
material  used  to  in- 
hibit  the  MLC 
1 h preincubation of inhibitor 
Final dilution or no. 
of  cells or cell equiva-  Without se- 
lent  (× 10  -6)  used 
rum 
With serum* immune to: 
Polyoma  MVM 
None  67.25 
Culture fluid  1:15  0.7  ND  ND 
1:50  11.9  7.4  67.8 
1:150  42.9  ND  ND 
1:500  65.0  ND  ND 
Ascites cells  4.0  -1.5  -0.7  64.8 
1.4  1.3  -1.3  56.0 
0.4  0.4  -0.5  ~.3 
Ascites cell sonicate  4.0  -1.1  -1.4  65.1 
1.4  -1.5  -0.5  66.4 
0.4  -0.1  1.1  59.2 
The following cultures were set up and harvested on day 6 for LMC at the 60/1 lymphocyte to 
target cell ratio: (a) BALB/c vs. C57BL/6 MLC  (triplicate cultures). Median LMC, 67.2~.  (b) 
MLC inhibited by various amounts of culture fluid, after 1 h preincubation without serum or 
with antipolyoma virus immune serum, or with anti-MVM immune serum,  as indicated. (c) 
MLC inhibited by various numbers of EL-4(G-) ascites cells from a cryopreserved pool, after 1 h 
preincubation, as indicated. (d) MLC inhibited by amounts of sonicate from and equivalent to 
various numbers of EL-4(G-) ascites cells, after 1 h preincubation, as indicated. 
*  1:100 dilutions of antipolyoma virus serum no. 12 and anti-MVM serum no. 9 were used. 
5 % LMC. 
that  each  system  may  contain  a  different factor,  and  that  there  is no  unique 
solution to the problem  of immunosuppression  by these tumor  cells.  We have 
earlier expressed the concern (reference 25 and footnote 1) that contamination  of 
the  transplantable  tumor  lines by infectious  and  immunosuppressive  agents, 
like mycoplasma  organisms  (26),  common murine  viruses (10,  27),  or the pres- 
ence  of immunosuppressive  endogenous  type  C  particles  (3,  28,  29)  may  not 
always have been adequately ruled out. The sublines of the C57BL/6 mouse EL-4 
lymphoma  used  in  this  and  the  preceding  studies  were  free  of mycoplasma 
contamination.~ They  have  been characterized  quite extensively for their  con- 
tent of endogenous type C  particles (reference 9 and footnote 3) and the data in 
this paper document  that  some of the sublines used were contaminated  with at 
least three other viruses: polyoma virus,  LDV,  and MVM. 
Chronologically, the first observation which we had made 1 was that EL-4(G-) 
ascites  cells inhibited  allogeneic reactions,  and  in  particular  the  BALB/c  vs. 
C57BL/6 MLC, as assessed by lymphoblast counts, [3H]thymidine incorporation, 
and LMC. Several pieces of  evidence suggested that a contaminating virus was 
responsible for  the inhibition in that earlier  study. Sonicates of  EL-4(G-) cells, 
filtered  culture fluids  of early in vitro passages of EL-4(G-) cells,  and spleen BONNARD,  MANDERS,  CAMPBELL,  HERBERMAN,  AND  COLLINS 
TABLE VII 
Effect on the MLC of Prototype Strains of MVM and of Kilham Rat Virus 
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Addition to MLC  Hemagglutina-  tion titer*  Volume added 
LMC at the lymphocyte to 
target cell ratios 
20/1  60/1 
ml  %  % 
None  --  54.7  74.0 
Culture  Fluid  Nones  3 × 10  -~  -0.5  -0.5 
10  -1  1.3  6.9 
3  ×  10 -2  18.7  41.7 
10  -2  35.3  66.2 
Prototype MVM no. 1  256  10  -2  67.3  81.5 
10  -3  66.6  81.2 
10  -4  61.9  82.0 
10  -s  70.6  81.6 
Prototype MVM no. 2  32  10  -2  56.8  75.1 
10  -3  60.0  75.8 
10  -4  55.3  79.3 
10  -5  67.5  83.7 
Kilham rat virus  2,512  5 × 10  -~  51.7  78.2 
1.5 × 10  -~  44.1  71.3 
The following cultures were set up and harvested on day 6 for LMC at two different lymphocyte 
to target cellratios: (a) BALB/c vs. C57BL/6 MLC (triplicate  cultures).  (b) MLC with various 
doses of the culture  fluid. (c) MLC with various doses of the prototype MVM strain no. 1. (d) 
MLC with  various doses of the prototype MVM strain no.  2.  (e) MLC with  two doses of the 
Kilham rat virus preparation. 
* Reciprocal of  the last dilution causing partial hemagglutination  of  guinea pig erythrocyte (15). 
$ No hemagglutination,  even by the undiluted culture  fluid. 
cells (or sonicates of spleen cells) of tumor-bearing mice were strongly inhibi- 
tory. The inhibitory activity was not due to the EL-4 cells themselves, since later 
passages of EL-4(G-) cells maintained in vitro, or another subline maintained 
in vivo, EL-4(G+), were not inhibitory. The acquisition by the originally nonin- 
hibitory EL-4(G+) line  of inhibitory properties,  8  mo after initiation of these 
studies was also consistent with an infectious inhibitory agent.  Kinetic studies 
of the responses in MLC or to the mitogen concanavalin A, and of the inhibition 
mediated  by EL-4(G-) cells,  revealed  that  a  latency period of 3-4  days was 
necessary  before  inhibition  could  be  observed;  this  suggested,  among  other 
possibilities, that viral replication was needed in these cultures before immuno- 
suppression could be seen. 
In the present study we concentrated our efforts on the characterization of the 
inhibitory activity of the culture fluid from an early in vitro passage of the EL- 
4(G-) cells. Thus, we would subsequently need to demonstrate that this inhibi- 
tory factor was identical with that in the EL-4(G-) ascites cells themselves. 
The factor in the culture fluid was characterized as a virus by simple biophysi- 
cal methods. The inhibitory factor was particulate (nondialyzable, sedimentable 
at 100,000 g  for i  h), very small (recovered after 0.10 pxn filtration), sensitive to 
UV irradiation but heat stable, and resistant to chloroform; it was infectious for 
EL-4(G-) tissue culture cells. The results of the MAP and LDV tests suggested 
that MVM or polyoma virus might be responsible for the inhibition.  But these 
results  did  not exclude other viruses.  LDV was ruled out,  because this virus 200  IMMUNOSUPPRESSIVE  VIRUS  IN  A  MURINE  TUMOR 
would not resist 56°C for 1 h or chloroform treatment (27), as did the inhibitory 
factor. Initial attempts to infect mouse embryo cells with the culture fluid were 
unsuccessful, so  that an  indirect characterization of the inhibitory factor by 
serological techniques seemed preferable. 
In preliminary experiments, cell-free ascitic fluids of mice bearing EL-4(G-) 
ascites were tested for inhibition of MLC. This might have occurred, particu- 
larly if LDV  were  the  agent,  since  LDV  has  been  reported  to  infect mice 
chronically, with high circulating titers of infectious virus (19, 20). However, 
such inhibition was seen only infrequently, as opposed to the constant inhibition 
seen with EL-4(G-) ascites cells, another argument to exclude LDV as a cause 
of inhibition.  We postulated then that the  reason why culture fluids would 
inhibit, and ascitic fluids would not,  might be the presence  in the ascites of 
sufficient antibodies to  neutralize the  inhibitory factor in  the  culture fluid. 
Further studies are needed to demonstrate that this effect indeed was due to 
neutralizing antibodies and to study their specificities. 
The data involving neutralization by the sera of mice immunized for the MAP 
test confirmed that the inhibitory factor in the culture fluid could be neutral- 
ized, and that it might be either polyoma virus or MVM.  Nonspecific serum 
factors or natural antibodies against the inhibitory factor in these NIH Swiss 
mice were formally excluded, because the sera of the controls had no effects. For 
neutralization of the culture fluid,  sera  of mice injected with the EL-4(G-) 
ascites cells were at least as effective as sera of mice immunized against the 
culture fluid itself. This provided the first clear evidence that the inhibitory 
factor in the culture fluid and in the EL-4(G-) ascites cells were the same. 
When reference immune sera against polyoma virus or MVM,  and control 
nonimmune sera, were used, only the anti-MVM sera neutralized the inhibition 
by the culture fluid or by the ascites cells. This indicated that the neutralization 
was mediated by specific neutralizing antibodies. If one accepts the evidence 
that the reference anti-MVM sera were specific for the prototype MVM, this 
data would then indicate that MVM was responsible for the inhibition seen. 
However, it must be remembered that the possibility always exists with any 
prototype virus strain, that it is contaminated with other unidentified viruses, 
against which reference immune sera might then also be active (10). Thus, we 
cannot dismiss the possibility that the inhibitory virus in EL-4(G-) cells and in 
the culture fluid is a  separate virus in the prototype MVM strain. Because we 
used three different anti-MVM immune sera produced against viruses grown in 
either mouse or rat embryo cells, a fortuitous contamination of one pool of MVM 
virus is unlikely, and we must envisage a systematic contamination of all pools. 
On the basis of this serological data, it is possible to rule out a  role for the 10 
other common rodent viruses in the MAP test panel, because the reference anti- 
MVM immune sera had no detectable activities against these viruses. 
The reference anti-MVM sera neutralized the inhibitory activity of EL-4(G-) 
ascites cells, sonicates, and culture fluid equally well. This indicated that the 
inhibitory factor in all materials was the same virus.  Similarly, it has been 
possible to neutralize the secondary culture fluids obtained after infection of the 
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Infectivity of the inhibitory factor was demonstrated by the inoculation of 
noninhibitory later passages of EL-4(G-) tissue culture cells, since they became 
strongly inhibitory upon such inoculation. Inhibition by the diluted inoculum 
itself was  excluded on  three  grounds.  (a)  The  cells  were  washed,  and  the 
medium was changed once or twice before harvest of the secondary inhibitory 
culture  fluids.  (b)  The  secondary culture  fluids  were  about  10  times  more 
inhibitory in  MLC  than the original inoculum.  (c) The cells, which initially 
could not inhibit MLC, became inhibitory. 
The  serologic  data  provided  strong  evidence in  favor  of MVM  being  the 
inhibitory virus in EL-4(G-)-derived materials, but this could not be confirmed 
by direct testing with two pools of prototype MVM.  Although both pools had 
significant hemagglutination titers (Table VII) and were readily infectious for 
both rat and mouse embryo cells, and for a mouse fibroblast cell line, attempts to 
produce inhibition  of MLC  with these pools  were unsuccessful.  Attempts to 
infect the later passages of EL-4(G-) cells with the prototype MVM (pool no. 2) 
have been unsuccessful so far, as measured by the induction of MVM antigens 
detectable by the fluorescent antibody technique (16), or by changes in growth 
rate of the cells (S. P. Staal, unpublished results). Therefore the prototype MVM 
seems to infect lymphoid cells with much less efficiency than fibroblasts.  The 
virus associated with EL-4(G-), however, possesses a tropism just the opposite 
to that of the prototype MVM. Attempts to detect infectivity in nonconfluent 
mouse fibroblasts by the appearance of cytopathogenicity or the induction of 
viral  antigens detectable by the fluorescent antibody technique  (using anti- 
MVM reference sera) have been negative; this virus, as assessed with the latter 
technique, readily infects virus-negative EL-4(G-) tissue culture cells and also 
lymphocytes in  MLC  (S.  P.  Staal,  unpublished  results).  Therefore, the EL- 
4(G-)-associated  virus  may represent  a  variant  murine  parvovirus  that  is 
lymphotropic, or a  different, unidentified virus. This will need to be grown in 
large quantities on EL-4(G-)  tissue culture cells,  and characterized further. 
Conversely, the prototype MVM may have lost its ability to grow in lymphoid 
cells  through  forced passage  in  fibroblasts.  Analysis  of the  ability  of fresh 
isolates of MVM to grow in lymphoid cells should solve this question. 
Our laboratory has recently examined in detail the immunosuppressive ef- 
fects of a dimethylbenzanthracen-induced  mammary adenocarcinoma in Fischer 
rats, 4 and found that inhibition of lymphocyte responses in vitro was due to 
Kilham rat virus (14), another parvovirus (D. A. Campbell and E. K. Manders, 
unpublished results). Kilham rat virus does not appear to grow in mouse cells 
(14,  15). Neutralizing  antibodies for MVM  and  Kilham rat  virus have been 
reported not to cross-react (30). Therefore, Kilham rat virus could hardly be the 
inhibitory virus in our mouse system and might not be expected to be active 
here.  Indeed, the data  in Table VII showed that Kilham rat virus,  at doses 
which strongly inhibited in  the rat  system,  would not inhibit  the cytotoxic 
mouse MLC response. 
4  Campbell, D. A., Jr.,  G. D. Bonnard, R. K. Oldham, and R. B. Herberman. Inhibition of 
proliferative  responses of  rat lymphocytes by tumor cells  and by spleen cells  from tumor-bearing 
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Many possible mechanisms for inhibition of MLC by the virus in the immuno- 
suppressive culture fluid need to be considered. A valuable approach with other 
immunosuppressive viruses, both in vivo and in vitro, has been to consider that 
the loss of immune response was due to the infection  with replication of the virus 
in the particular subset of cells which are committed to respond (3, 31-34). Since 
it is known that thymus-derived lymphocytes are mainly responsible for the 
proliferative and cytotoxic responses in mouse MLC (35), a simple hypothesis is 
that  the  immunosuppressive virus  infected the  thymus-derived spleen cells 
directly. The rather selective effects of this immunosuppressive virus on lym- 
phoblast  proliferation,  illustrated in  detail  in  the previous study, 1 and  the 
tropism of this virus for the EL-4 lymphoma, a thymus-derived lymphoma with 
characteristics of T lymphocytes (7, 8), including the ability to replicate vesicu- 
lar stomatitis virus (36), would be consistent with this hypothesis. The demon- 
stration that reference anti-MVM immune sera could neutralize the inhibitory 
factor, and the availability of immunofluorescent techniques (16) to recognize 
the virus in infected cells, shoud be of considerable help in longitudinal follow- 
up of MLC infected with our immunosuppressive virus and in the characteriza- 
tion  of the  precise  cells  which become infected within  the  responding cell 
population.  At present,  the possibility that cells other than thymus-derived 
lymphocytes, possibly infected macrophages, play a central role in the inhibition 
of MLC cannot be ruled out. 
If the infection of thymus-derived  proliferating lymphocytes  can be confirmed, 
it may be of some importance beyond the scope of this study. For instance, one 
might be able to detect antigen-reactive virus-sensitive T lymphocytes  by infec- 
tion with our immunosuppressive virus, and induction of antigens detectable 
with reference anti-MVM sera by the indirect immunofluorescence technique 
(16). This  may represent a  worthwhile addition to  the use  of the  vesicular 
stomatitis virus plaque assay for the characterization of antigen-reactive thy- 
mus-derived cells pioneered by Bloom and co-workers (32, 33). 
We have previously stressed the need for extensive testing of murine trans- 
plantable tumors on the one hand (reference 25 and footnote 1),  and murine 
virus stocks on the other hand (10) for contamination by microbiological agents, 
and in particular by common murine viruses. If experiments are performed  with 
contaminated materials, they may lead to erroneous conclusions. This problem 
is particularly important in experimental tumor immunology, because we need 
a  clear understanding of the relationships between tumors and viruses,  and 
between each of these and the host immune response. The present experiments 
demonstrated that a virus found in a subline of the EL-4 lymphoma, completely 
inhibited the cytotoxic response of  mouse lymphocytes  to alloantigens. They also 
raised some doubt as to the purity of the prototype MVM strain and as to the 
monospecificity  of the widely used reference anti-MVM immune sera. Contami- 
nation of the tumor cells with this immunosuppressive virus critically affected 
the  response  of allogeneic lymphocytes to  these  tumor cells,  which  in  the 
absence of viral contamination readily elicited the normal expected allogeneic 
response. 1  The recognition of this and other potential immunosuppressive con- 
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preceding  studies  (reference  25  and  footnote  1),  or used  here,  represents  an 
essential step towards a better understanding of antigenicity and immunogenic- 
ity of tumor cells in various murine systems. The in vivo host response to tumors 
like the widely used EL-4 may be adversely affected by contamination  of the 
tumor inoculum and the possibility exists that such viruses interfere with the 
experimentation on syngeneic lymphocyte responses to tumor cells in vitro. 
Summary 
Filtered  culture fluids from the  early in vitro passages of a  subline of the 
C57BL/6  mouse  EL-4  lymphoma,  EL-4(G-),  were  strongly  inhibitory  for 
BALB/c vs. C57BL/6 mixed lymphocyte cultures (MLC). The inhibitory activity 
could  be  preserved  by  storage  at  -75°C  or  4°C,  thus  allowing  its  further 
characterization. The inhibitory factor was particulate (nondialyzable, sediment- 
able  at  100,000  g  for  1  h),  very  small  (recovered  after  0.10  ~m  filtration), 
sensitive to UV irradiation,  but heat stable (56°C,  1 h) and resistant to chloro- 
form. It was infectious, since later, noninhibitory passages of EL-4(G-) tissue 
culture cells became strongly inhibitory upon inoculation with the culture fluid. 
This data was consistent with the inhibitory factor being an infectious virus. 
Virus analysis by mouse antibody production tests revealed that viruses were 
indeed present in EL-4(G-) ascites cells and in the culture fluid, and not in a 
late passage of EL-4(G-) tissue culture cells which were not inhibitory. Neutral- 
ization of the inhibitory factor was achieved by pretreatment with ascitic fluid or 
with the sera raised against those EL-4(G-)-derived materials which contained 
viruses.  Mouse reference  immune  sera  against  minute  virus of mice  (MVM) 
completely neutralized the inhibitory factor in the culture fluid or in EL-4(G-) 
ascites cells. Two prototype MVM strains,  and one Kilham rat virus prepara- 
tion, did not inhibit the mouse MLC. Thus, the possibility exists that a variant 
of MVM, or an unidentified virus, has been grown and selected for in EL-4(G-) 
cells  and  recognized,  due  to  its  immunosuppressive  characteristics.  In  any 
event,  immunosuppression  by EL-4(G-) cells was not mediated by the tumor 
cells, their metabolic products, or associated endogenous type C viruses, but by 
an  exogenous  virus,  most  likely  a  variant  MVM  with  immunosuppressive 
characteristics.  This adds weight to a parallel observation from our laboratory 
on the immunosuppressive effects of Kilham  rat virus in rat  lymphocyte cul- 
tures. 
We thank Dr. S. P. Staal for making his results available to us, and contributing to the discussion. 
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